Selected research
Industry Research
Drug Concentration Detection Industry Research Report 2026
Market perspective
The global Drug Concentration Detection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Drug Concentration Detection market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Drug Concentration Detection market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Drug Concentration Detection market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Drug Concentration Detection include Thermo Fisher Scientific, Abbott, ACROBiosystems, bioMerieux, Bio-Rad Laboratories, Bühlmann Laboratories, Danaher, Randox Laboratories and Roche, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Drug Concentration Detection market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Drug Concentration Detection.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Drug Concentration Detection Market by Company
Thermo Fisher Scientific
Abbott
ACROBiosystems
bioMerieux
Bio-Rad Laboratories
Bühlmann Laboratories
Danaher
Randox Laboratories
Roche
Sekisui Medical
Siemens Healthineers
Shanghai Genext Medical Technology
Beijing Chromai
Beijing IPHASE
Beijing Diagreat
Beijing Haosi Biotech
Drug Concentration Detection Segment by Type
Blood Detection
Urine Detection
Others
Drug Concentration Detection Segment by Application
Hospital
Clinic
Others
Drug Concentration Detection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Concentration Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Concentration Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Concentration Detection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Drug Concentration Detection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Blood Detection
- Urine Detection
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- Thermo Fisher Scientific
- Abbott
- ACROBiosystems
- bioMerieux
- Bio-Rad Laboratories
- Bühlmann Laboratories
- Danaher
- Randox Laboratories
- Roche
- Sekisui Medical
- Siemens Healthineers
- Shanghai Genext Medical Technology
- Beijing Chromai
- Beijing IPHASE
- Beijing Diagreat
- Beijing Haosi Biotech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Drug Concentration Detection by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Blood Detection
- 2.2.3 Urine Detection
- 2.2.4 Others
- 2.3 Drug Concentration Detection by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Drug Concentration Detection Breakdown Data by Type
- 3.1 Global Drug Concentration Detection Historic Market Size by Type (2021-2026)
- 3.2 Global Drug Concentration Detection Forecasted Market Size by Type (2027-2032)
4 Drug Concentration Detection Breakdown Data by Application
- 4.1 Global Drug Concentration Detection Historic Market Size by Application (2021-2026)
- 4.2 Global Drug Concentration Detection Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Drug Concentration Detection Market Perspective (2021-2032)
- 5.2 Global Drug Concentration Detection Growth Trends by Region
- 5.2.1 Global Drug Concentration Detection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Drug Concentration Detection Historic Market Size by Region (2021-2026)
- 5.2.3 Drug Concentration Detection Forecasted Market Size by Region (2027-2032)
- 5.3 Drug Concentration Detection Market Dynamics
- 5.3.1 Drug Concentration Detection Industry Trends
- 5.3.2 Drug Concentration Detection Market Drivers
- 5.3.3 Drug Concentration Detection Market Challenges
- 5.3.4 Drug Concentration Detection Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Drug Concentration Detection Players by Revenue
- 6.1.1 Global Top Drug Concentration Detection Players by Revenue (2021-2026)
- 6.1.2 Global Drug Concentration Detection Revenue Market Share by Players (2021-2026)
- 6.2 Global Drug Concentration Detection Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Drug Concentration Detection Head Office and Area Served
- 6.4 Global Drug Concentration Detection Players, Product Type & Application
- 6.5 Global Drug Concentration Detection Manufacturers Established Date
- 6.6 Global Drug Concentration Detection Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Drug Concentration Detection Market Size (2021-2032)
- 7.2 North America Drug Concentration Detection Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Drug Concentration Detection Market Size by Country (2021-2026)
- 7.4 North America Drug Concentration Detection Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Drug Concentration Detection Market Size (2021-2032)
- 8.2 Europe Drug Concentration Detection Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Drug Concentration Detection Market Size by Country (2021-2026)
- 8.4 Europe Drug Concentration Detection Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Drug Concentration Detection Market Size (2021-2032)
- 9.2 Asia-Pacific Drug Concentration Detection Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Drug Concentration Detection Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Drug Concentration Detection Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Drug Concentration Detection Market Size (2021-2032)
- 10.2 South America Drug Concentration Detection Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Drug Concentration Detection Market Size by Country (2021-2026)
- 10.4 South America Drug Concentration Detection Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Drug Concentration Detection Market Size (2021-2032)
- 11.2 Middle East & Africa Drug Concentration Detection Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Drug Concentration Detection Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Drug Concentration Detection Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermo Fisher Scientific
- 12.1.1 Thermo Fisher Scientific Company Information
- 12.1.2 Thermo Fisher Scientific Business Overview
- 12.1.3 Thermo Fisher Scientific Revenue in Drug Concentration Detection Business (2021-2026)
- 12.1.4 Thermo Fisher Scientific Drug Concentration Detection Product Portfolio
- 12.1.5 Thermo Fisher Scientific Recent Developments
- 12.2 Abbott
- 12.2.1 Abbott Company Information
- 12.2.2 Abbott Business Overview
- 12.2.3 Abbott Revenue in Drug Concentration Detection Business (2021-2026)
- 12.2.4 Abbott Drug Concentration Detection Product Portfolio
- 12.2.5 Abbott Recent Developments
- 12.3 ACROBiosystems
- 12.3.1 ACROBiosystems Company Information
- 12.3.2 ACROBiosystems Business Overview
- 12.3.3 ACROBiosystems Revenue in Drug Concentration Detection Business (2021-2026)
- 12.3.4 ACROBiosystems Drug Concentration Detection Product Portfolio
- 12.3.5 ACROBiosystems Recent Developments
- 12.4 bioMerieux
- 12.4.1 bioMerieux Company Information
- 12.4.2 bioMerieux Business Overview
- 12.4.3 bioMerieux Revenue in Drug Concentration Detection Business (2021-2026)
- 12.4.4 bioMerieux Drug Concentration Detection Product Portfolio
- 12.4.5 bioMerieux Recent Developments
- 12.5 Bio-Rad Laboratories
- 12.5.1 Bio-Rad Laboratories Company Information
- 12.5.2 Bio-Rad Laboratories Business Overview
- 12.5.3 Bio-Rad Laboratories Revenue in Drug Concentration Detection Business (2021-2026)
- 12.5.4 Bio-Rad Laboratories Drug Concentration Detection Product Portfolio
- 12.5.5 Bio-Rad Laboratories Recent Developments
- 12.6 Bühlmann Laboratories
- 12.6.1 Bühlmann Laboratories Company Information
- 12.6.2 Bühlmann Laboratories Business Overview
- 12.6.3 Bühlmann Laboratories Revenue in Drug Concentration Detection Business (2021-2026)
- 12.6.4 Bühlmann Laboratories Drug Concentration Detection Product Portfolio
- 12.6.5 Bühlmann Laboratories Recent Developments
- 12.7 Danaher
- 12.7.1 Danaher Company Information
- 12.7.2 Danaher Business Overview
- 12.7.3 Danaher Revenue in Drug Concentration Detection Business (2021-2026)
- 12.7.4 Danaher Drug Concentration Detection Product Portfolio
- 12.7.5 Danaher Recent Developments
- 12.8 Randox Laboratories
- 12.8.1 Randox Laboratories Company Information
- 12.8.2 Randox Laboratories Business Overview
- 12.8.3 Randox Laboratories Revenue in Drug Concentration Detection Business (2021-2026)
- 12.8.4 Randox Laboratories Drug Concentration Detection Product Portfolio
- 12.8.5 Randox Laboratories Recent Developments
- 12.9 Roche
- 12.9.1 Roche Company Information
- 12.9.2 Roche Business Overview
- 12.9.3 Roche Revenue in Drug Concentration Detection Business (2021-2026)
- 12.9.4 Roche Drug Concentration Detection Product Portfolio
- 12.9.5 Roche Recent Developments
- 12.10 Sekisui Medical
- 12.10.1 Sekisui Medical Company Information
- 12.10.2 Sekisui Medical Business Overview
- 12.10.3 Sekisui Medical Revenue in Drug Concentration Detection Business (2021-2026)
- 12.10.4 Sekisui Medical Drug Concentration Detection Product Portfolio
- 12.10.5 Sekisui Medical Recent Developments
- 12.11 Siemens Healthineers
- 12.11.1 Siemens Healthineers Company Information
- 12.11.2 Siemens Healthineers Business Overview
- 12.11.3 Siemens Healthineers Revenue in Drug Concentration Detection Business (2021-2026)
- 12.11.4 Siemens Healthineers Drug Concentration Detection Product Portfolio
- 12.11.5 Siemens Healthineers Recent Developments
- 12.12 Shanghai Genext Medical Technology
- 12.12.1 Shanghai Genext Medical Technology Company Information
- 12.12.2 Shanghai Genext Medical Technology Business Overview
- 12.12.3 Shanghai Genext Medical Technology Revenue in Drug Concentration Detection Business (2021-2026)
- 12.12.4 Shanghai Genext Medical Technology Drug Concentration Detection Product Portfolio
- 12.12.5 Shanghai Genext Medical Technology Recent Developments
- 12.13 Beijing Chromai
- 12.13.1 Beijing Chromai Company Information
- 12.13.2 Beijing Chromai Business Overview
- 12.13.3 Beijing Chromai Revenue in Drug Concentration Detection Business (2021-2026)
- 12.13.4 Beijing Chromai Drug Concentration Detection Product Portfolio
- 12.13.5 Beijing Chromai Recent Developments
- 12.14 Beijing IPHASE
- 12.14.1 Beijing IPHASE Company Information
- 12.14.2 Beijing IPHASE Business Overview
- 12.14.3 Beijing IPHASE Revenue in Drug Concentration Detection Business (2021-2026)
- 12.14.4 Beijing IPHASE Drug Concentration Detection Product Portfolio
- 12.14.5 Beijing IPHASE Recent Developments
- 12.15 Beijing Diagreat
- 12.15.1 Beijing Diagreat Company Information
- 12.15.2 Beijing Diagreat Business Overview
- 12.15.3 Beijing Diagreat Revenue in Drug Concentration Detection Business (2021-2026)
- 12.15.4 Beijing Diagreat Drug Concentration Detection Product Portfolio
- 12.15.5 Beijing Diagreat Recent Developments
- 12.16 Beijing Haosi Biotech
- 12.16.1 Beijing Haosi Biotech Company Information
- 12.16.2 Beijing Haosi Biotech Business Overview
- 12.16.3 Beijing Haosi Biotech Revenue in Drug Concentration Detection Business (2021-2026)
- 12.16.4 Beijing Haosi Biotech Drug Concentration Detection Product Portfolio
- 12.16.5 Beijing Haosi Biotech Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst